Immunotherapy is a widely used method for treatment of several types of cancers including lung cancer, bladder cancer and more. Immune-based treatments for cancers have raised hope of doctors as well as…
Tag: Treatment of Lung Cancer
Chemotherapy and Immunotherapy Combination to Provide Effective Lung Cancer Treatment
According to a study published in Science Translational Medicine, a combination of two cancer treatments could provide effective treatment for lung cancer by targeting immune cells involved with formulation of tumors. The…
Indian Scientists Develop 3D Robotic Motion Phantom for Lung Cancer Treatment
Indian scientists have developed a novel three-dimensional robotic motion phantom that is capable of reproducing human lung motion. This robotic motion has been developed by Ashish Dutta, Professor at IIT Kanpur, Professor…
Palliative Care and Lung Cancer
The deadly disease of lung cancer occurs when the cells in lung grow uncontrollably and form a mass called as tumor. This lung cancer can begin anywhere in the lung and once…
What is Combination Therapy for Metastatic Lung Cancer?
Most of the times, lung cancer is found when it has already spread to other parts of the body. It may have travel to lymph nodes near or away from lung, the…
FDA Approves First Targeted Therapy for Lung Cancer with Specific Genetic Mutation
The U.S. Food and Drug Administration has approved Lumakras (sotorasib) as first treatment for non-small cell lung cancer patients whose tumors have specific type of genetic mutation called KRAS G12C. It is…
Topotecan–Berzosertib Combination Effective for SCLC Treatment
Researchers all over the world are continuously been working towards finding effective treatments and therapies for lung cancer. There are widely two types of lung cancer: small cell lung cancer (SCLC) and…
FDA Approves Libtayo as Monotherapy for Advanced NSCLC
Lung cancer is one of the leading causes of cancer-related deaths worldwide. In the year 2020, an estimated 225,000 new cases were diagnosed in the United States. Also, approximately 84% of all…